The American Cancer Society (ACS) today announced the launch of its fourth medical journal, Pediatric, Adolescent & Young Adult Cancer. This international, multidisciplinary publication will feature peer-reviewed original research and solicited content on the latest advances in cancers affecting children,

A group of scientists with the University of Texas at Austin and MD Anderson Cancer Center discovered that a potential chemotherapy drug was causing an immune response that usually occurs in response to viral infections.

An enduring challenge for the study of human cancer is just how complex it is: how many different ways there are for cancers to originate, progress, and spread in the people who are diagnosed with them. In a review published on January 29th, 2025 in the ...

As we venture further into space and increasingly use low Earth orbit for in-space manufacturing, the potential for the development of innovative technologies appears to be infinite. For these discoveries,

In the British Journal of Cancer, a recent article from MSU SSRC Giles Distinguished Professor Emeritus Arthur G. Cosby and a team of researchers analyzed cancer deaths in almost 3,000 U.S. counties from 1981-2019,

CLEVELAND, Ohio —Bacteria inside cancerous tumors may be a key reason why immunotherapy works for some patients but not others, researchers from the Cleveland Clinic and other institutes have discovered. Two new studies, published simultaneously in the ...

Cedars-Sinai Health Sciences University investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver cancer. Findings from the preclinical study were published in Cell Death & Disease.

Forbes contributors publish independent expert analyses and insights. Peter Suciu covers trends in the world of aerospace and defense. Social media has become a breeding ground for misinformation, and while some of it could be harmless, it can also impact ...